Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 86 of 95, showing 5 Applications out of 471 total, starting on record 426, ending on 430

# Protocol No Study Title Investigator(s) & Site(s)

426.

ECCT/13/03/01  
    Assessing the acceptability of a progesterone vaginal ring (PVR) as a new contraceptive option in sub-Saharan Africa   
Principal Investigator(s)
1. Obare Francis
Site(s) in Kenya
1. Ngoliba Health Centre (Kiambu county)
2. Kirwara Sub-district Hospital (Kiambu county)
3. Igegania Sub-district Hospital (Kiambu county)
4. Makadara Health Centre (Nairobi City county)
5. Thika Level 5 (Kiambu county)
6. Ruiru Sub-district Hospital (Kiambu county)
 
View

427.

ECCT/13/02/01   AMC 068
    A Randomized Phase II Trial Of Chop Vs Oral Chemotherapy with Concomitant Antiretroviral Therapy in Patients with HIV-Associated Lymphoma in Sub-Saharan Africa   
Principal Investigator(s)
1. NAFTALI WISINDI BUSAKHALA
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH CENTER
 
View

428.

ECCT/13/01/01  
        An Open Label Randomized Controlled Phase IIb Trial to Determine the Safety of Oral Fluconazole in Combination with Flucytosine as Compared to Fluconazole Alone   
Principal Investigator(s)
1. Ana-Claire Meyer
2. Judith Kwasa
3. Mark Jacobson
Site(s) in Kenya
1. Family AIDS Care and Education Services, Lumumba Health Center (Kisumu county)
2. Family AIDS Care and Education Services, Suba District Hospital (Homa Bay county)
 
View

429.

ECCT/12/12/01  
        A pilot study to optimise controlled human malaria infections in humans with varying degrees of prior exposure to malaria using P. falciparum sporozoites administered by needle and syringe   
Principal Investigator(s)
1. Bernhards Ogutu
2. Kevin Marsh
Site(s) in Kenya
Kenya Medical Research Institute, Centre for Clinical Research, Nairobi
 
View

430.

ECCT/12/11/03   Rifampin-Based TB Treatment vs. Rifabutin-Based TB Treatment in HIV
    A5290 "A Randomized, Phase 2b Study of a Double-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifampin-Based Tuberculosis Treatment versus a Standard-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifabutin-Based Tuberculosis Treatment with or without Raltegravir in HIV-1-Infected Persons Requiring Treatment for Active TB and HIV"          
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
View